When it comes to ADHD medication, there is no single option that works best for everyone. Several different medications are available in Australia, each with distinct characteristics that make them more or less suitable depending on the individual. Understanding the differences can help you have more productive conversations with your prescribing doctor.
This article provides a factual comparison of ADHD medications available in Australia. It is not a recommendation for any specific treatment. All medication decisions should be made with your healthcare team.
Categories of ADHD Medication
ADHD medications available in Australia fall into two main categories:
Stimulant Medications
Stimulants are the most commonly prescribed ADHD medications and have the most extensive evidence base. They work by increasing the availability of dopamine and norepinephrine in the brain.
Non-Stimulant Medications
Non-stimulants work through different mechanisms and may be preferred when stimulants are not suitable, not effective, or cause intolerable side effects. In Australia, two non-stimulant medications are PBS-listed for ADHD: atomoxetine (Strattera) and guanfacine (Intuniv). Non-stimulants are not classified as Schedule 8 controlled substances, which means they have fewer prescribing restrictions and may be easier to access in some circumstances.
Methylphenidate-Based Medications
Methylphenidate is available in several formulations in Australia:
Ritalin (Immediate-Release)
- Active ingredient: Methylphenidate hydrochloride
- Duration of action: Approximately 3-4 hours
- Dosing: Usually taken 2-3 times daily
- Advantages: Flexible dosing, quick onset (30-60 minutes), allows fine-tuning of when effects are needed, lower cost per tablet
- Considerations: Requires multiple daily doses, effects can be inconsistent as the medication peaks and troughs throughout the day
Ritalin LA (Extended-Release)
- Active ingredient: Methylphenidate hydrochloride in a modified-release capsule
- Duration of action: Approximately 8 hours
- Dosing: Once daily in the morning
- Advantages: Single morning dose, more consistent symptom coverage during the day, capsule can be opened and sprinkled on food
- Considerations: Less flexibility for adjusting coverage later in the day, may not last long enough for evening activities
Concerta (Extended-Release OROS)
- Active ingredient: Methylphenidate hydrochloride using OROS (Osmotic-Controlled Release Oral Delivery System)
- Duration of action: Approximately 12 hours
- Dosing: Once daily in the morning
- Advantages: Long duration provides coverage for a full working or school day, steady release profile reduces peaks and troughs
- Considerations: Cannot be cut or crushed, longer duration means effects may interfere with evening appetite or sleep in some people, the non-absorbable shell may be visible in stool (this is normal)
Amphetamine-Based Medications
Dexamfetamine (Immediate-Release)
- Active ingredient: Dexamfetamine sulfate
- Duration of action: Approximately 3-5 hours
- Dosing: Usually taken 2-3 times daily
- Advantages: Well-established medication with decades of use, flexible dosing, may work for people who do not respond well to methylphenidate
- Considerations: Requires multiple daily doses, Schedule 8 controlled substance with strict dispensing rules
Vyvanse (Lisdexamfetamine)
- Active ingredient: Lisdexamfetamine dimesylate (a prodrug that is converted to dexamfetamine in the body)
- Duration of action: Approximately 10-14 hours
- Dosing: Once daily in the morning
- Advantages: Long duration, smooth onset and offset, prodrug design means it must be metabolised before becoming active (which may reduce potential for misuse), available in multiple strengths for precise dosing
- Considerations: Long duration means it cannot be “topped up” with a second dose easily, may affect sleep in some people, generally more expensive than immediate-release options
Non-Stimulant Medications
Strattera (Atomoxetine)
- Active ingredient: Atomoxetine hydrochloride
- Mechanism: Selective norepinephrine reuptake inhibitor
- Duration of action: Continuous (taken daily to maintain therapeutic levels)
- Dosing: Once or twice daily
- Advantages: Not a stimulant, so not a controlled substance and may have lower risk of misuse; provides 24-hour symptom coverage; may be particularly helpful for co-occurring anxiety; does not worsen tic disorders
- Considerations: Takes 4-6 weeks to reach full effect (unlike stimulants which work on the same day); may be less effective than stimulants for some people; side effects can include nausea, decreased appetite, and mood changes during the adjustment period
Intuniv (Guanfacine Extended-Release)
- Active ingredient: Guanfacine hydrochloride
- Mechanism: Alpha-2A adrenergic agonist
- Duration of action: Continuous (taken daily)
- Dosing: Once daily
- Advantages: Non-stimulant option; may be particularly helpful for hyperactivity and impulsivity; can be used as an add-on to stimulant medication; may help with emotional dysregulation; does not worsen tics
- Considerations: May cause sedation, especially when starting; can lower blood pressure; takes several weeks to reach full effect; must be tapered gradually if discontinuing (do not stop suddenly)
How Doctors Choose Between Medications
Prescribing doctors consider multiple factors when recommending an ADHD medication:
- Symptom profile — which symptoms are most prominent (inattention vs hyperactivity vs impulsivity)
- Duration of coverage needed — does the person need coverage for school or work hours only, or for evening activities as well
- Co-occurring conditions — anxiety, depression, tic disorders, substance use history, and cardiovascular health all influence medication choice
- Previous medication trials — what has been tried before and how the person responded
- Individual response — some people respond better to methylphenidate, others to amphetamines, and predicting which will work best for a specific person is not always possible
- Side effect profile — which potential side effects are most concerning for the individual
- Practical considerations — ability to remember multiple daily doses, cost, and access to specialist prescribers
- Patient preference — the person’s own values, concerns, and treatment goals
PBS Coverage and Cost Comparison
The cost of ADHD medications varies significantly depending on the specific medication, whether it is prescribed under the PBS, and whether you hold a concession card. Understanding these differences can be an important factor in medication decisions.
PBS-Listed Medications
All the medications described in this article are listed on the PBS for ADHD, meaning they are available at subsidised prices for eligible patients. However, the private (non-PBS) cost differs significantly between medications:
- Methylphenidate immediate-release (Ritalin): Among the least expensive options, particularly in generic form
- Methylphenidate extended-release (Ritalin LA, Concerta): Moderately priced; Concerta tends to be more expensive due to its specialised OROS delivery system
- Dexamfetamine: Generally the least expensive ADHD medication in Australia
- Lisdexamfetamine (Vyvanse): One of the more expensive options, particularly at higher doses
- Atomoxetine (Strattera): Moderately priced, with generic options becoming available
- Guanfacine (Intuniv): Extended-release formulation tends to be moderately priced
Under PBS subsidisation, the patient co-payment is the same regardless of which listed medication is prescribed. The difference in cost becomes relevant when medications are prescribed privately (without PBS authority) or when you are comparing medications during the titration period.
Authority Prescription Requirements
All PBS-listed ADHD medications require an authority prescription, meaning your prescriber must obtain approval from Services Australia before the PBS subsidy applies. The authority requirements differ slightly between medications and between initial and continuing treatment. Your prescribing specialist will manage this process, but it is worth being aware that delays in authority approval can sometimes cause gaps in medication supply.
Combination Medication Strategies
In some cases, a single medication may not adequately address all ADHD symptoms throughout the day. When this occurs, prescribers may recommend combination approaches:
Stimulant Combinations
- Extended-release base with immediate-release top-up: A common approach involves taking an extended-release medication in the morning for all-day coverage, supplemented by a small dose of immediate-release medication in the late afternoon for evening tasks. For example, Concerta in the morning with a small dose of immediate-release Ritalin in the afternoon.
- Two different formulations of the same class: Some prescribers use two different extended-release formulations to achieve a specific coverage profile that a single formulation cannot provide.
Stimulant Plus Non-Stimulant
- Adding guanfacine to a stimulant: Guanfacine may be added to a stimulant medication to address residual hyperactivity, impulsivity, or emotional dysregulation. The TGA approves guanfacine as both a standalone treatment and as an adjunct to stimulant therapy.
- Adding atomoxetine to a stimulant: Less commonly, atomoxetine may be used alongside a stimulant, though this combination requires careful monitoring.
Combination strategies should only be undertaken under specialist supervision with appropriate monitoring.
Medication and Co-occurring Conditions
ADHD rarely exists in isolation. Many people with ADHD have co-occurring conditions that influence medication choice:
ADHD and Anxiety
Anxiety disorders co-occur with ADHD in approximately 30 to 50 per cent of cases. Some considerations include:
- Stimulant medications can occasionally worsen anxiety in some individuals, though for others, treating the ADHD actually reduces anxiety by improving their ability to manage daily demands
- Atomoxetine (Strattera) may be particularly helpful when ADHD and anxiety co-occur, as it has shown benefits for both conditions
- Guanfacine can have calming effects that may benefit co-occurring anxiety
- If a stimulant is chosen, careful titration with close monitoring for anxiety symptoms is important
ADHD and Depression
Depression commonly co-occurs with ADHD. Treating the ADHD can sometimes improve depressive symptoms, but concurrent antidepressant treatment may also be needed. Your psychiatrist will consider potential interactions between ADHD medications and antidepressants.
ADHD and Tic Disorders
Tic disorders (including Tourette’s syndrome) can co-occur with ADHD. While there was a historical concern that stimulant medications might worsen tics, more recent research suggests that appropriately dosed stimulants are generally safe for people with tics. Guanfacine is sometimes preferred in this context, as it can help manage both ADHD symptoms and tics.
ADHD and Substance Use History
A history of substance use does not automatically preclude the use of stimulant medication, but it does require careful consideration:
- Lisdexamfetamine (Vyvanse) may be preferred because its prodrug design means it has a slower onset, reducing its potential for misuse
- Non-stimulant options (atomoxetine, guanfacine) carry no risk of stimulant misuse
- Close monitoring and structured dispensing arrangements may be appropriate
- Research suggests that treating ADHD in people with a substance use history may actually reduce the risk of ongoing substance use
ADHD and Cardiovascular Conditions
All stimulant medications can modestly increase heart rate and blood pressure. A thorough cardiovascular assessment before starting treatment is essential. People with pre-existing heart conditions, significant family history of cardiac problems, or uncontrolled hypertension require specialist cardiology input before starting stimulant medication. Non-stimulant options may be preferred in some cardiac situations, though guanfacine can lower blood pressure, which is also relevant.
The Trial-and-Error Process
It is common for the first medication tried not to be the best option. Finding the right medication and dose is often a process of careful trial and adjustment. Your doctor may:
- Start with one medication at a low dose
- Gradually increase the dose while monitoring effects and side effects
- Switch to a different medication if the first does not work well
- Try combining medications in some cases
- Adjust the treatment plan as your needs change over time
This process requires patience and open communication with your prescribing doctor. Keeping a daily log of how you feel at different times of day can be extremely helpful.
Important Reminders
- No medication is “better” than another in absolute terms — the best medication is the one that works best for you with the fewest side effects
- Medication is most effective as part of a comprehensive treatment plan that includes non-medication strategies
- Never change your medication without discussing it with your prescribing doctor
- Do not compare your medication experience to others’ — individual responses vary significantly
- All ADHD medications in Australia are subject to regulatory oversight by the TGA
Frequently Asked Questions
Can I switch medications if my current one is not working?
Yes. It is common for the first medication tried not to be the optimal choice. If your current medication is not providing adequate symptom control or is causing problematic side effects, discuss switching with your prescribing doctor. The switch may involve tapering one medication while starting another, or in some cases a direct change. Your doctor will manage this process safely.
Is it normal to try multiple medications before finding the right one?
Yes. Finding the right ADHD medication is often described as an iterative process. Research suggests that approximately 70 to 80 per cent of people respond to at least one stimulant medication, but determining which specific medication and dose is best requires systematic trial and evaluation. Some people find their ideal medication quickly, while others may try two or three options before settling on the best fit.
Why do some people respond to methylphenidate but not amphetamines, or vice versa?
Despite both being stimulant medications, methylphenidate and amphetamine-based drugs work through slightly different mechanisms. Individual genetic variations in how the brain processes and responds to these medications likely account for the different response patterns. There is currently no commercially available genetic test that reliably predicts which medication will work best for a specific person, though research in pharmacogenomics is ongoing.
Can I take ADHD medication only on days I need it?
For immediate-release stimulant medications, some people (in consultation with their doctor) take medication only on days when they need symptom coverage, such as work or study days, and skip it on weekends or holidays. This approach is more common with shorter-acting medications. Extended-release formulations are generally taken daily. Non-stimulant medications (atomoxetine and guanfacine) must be taken daily to maintain their therapeutic effect and should not be taken intermittently.
How do I know if my dose needs adjusting?
Signs that your dose may need adjustment include the medication wearing off too early in the day, inadequate symptom control despite consistent use, side effects that are bothersome or worsening, symptoms returning after a period of good control (which may relate to tolerance, stress, or other factors), and significant changes in body weight (particularly in children). Regular review appointments with your prescribing specialist are the best way to identify when dose adjustments are needed.
Are there ADHD medications available overseas that are not available in Australia?
Yes, there are several ADHD medications available in other countries that are not currently TGA-approved or PBS-listed in Australia. These include certain extended-release formulations, combination products, and newer medications. If you believe a medication available overseas might be beneficial for your situation, discuss it with your specialist. In some cases, access may be possible through the TGA’s Special Access Scheme.
Support Services
If you have questions about ADHD treatment options:
- ADHD Australia: adhdaustralia.org.au — information and support
- Beyond Blue: 1300 22 4636 — mental health support, available 24/7
- Lifeline: 13 11 14 — crisis support, available 24/7
This article provides general information only and is not a substitute for professional medical advice. Medication decisions should always be made in consultation with your prescribing doctor based on your individual circumstances.